We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Scientific Session Explores Future Role of AI and ML in Clinical Laboratory

By LabMedica International staff writers
Posted on 26 Jul 2023
Print article
Image: AI and machine learning are expected to play a significant role in clinical laboratories (Photo courtesy of Freepik)
Image: AI and machine learning are expected to play a significant role in clinical laboratories (Photo courtesy of Freepik)

The enthusiasm surrounding the application of artificial intelligence (AI) and machine learning (ML) in laboratory medicine is unprecedented. This makes it crucial for laboratory professionals to acquire fundamental knowledge of these systems as they are set to become an integral part of clinical practice. At the AACC 2023 scientific session, “Artificial Intelligence and Machine Learning in the Clinical Laboratories: Fundamental Concepts, Clinical Use Cases, and Future Considerations,” attendees learned about the role that AI and ML can play in the clinical laboratory.

Considering the enormous amount of data produced by laboratories, the potential for implementing AI algorithms across all stages of the testing procedure is immense. Nonetheless, to truly harness the power of these algorithms, it's essential to understand and appreciate the functioning of such models. In the first part of the session, Christopher Williams, MD, from the University of Oklahoma Health Sciences Center (Oklahoma City, OK, USA) taught attendees some of the foundational concepts of AI and ML. Williams introduced various types of ML, a subset of AI that includes supervised and unsupervised learning. Williams laid out an understanding of the core concepts that can empower laboratorians to begin questioning why a model makes certain decisions—a skill that can prove useful for those evaluating their own models as well as for those approached by vendors with AI-enabled products.

In the second part of the session, David McClintock, MD, from Mayo Clinic (Rochester, MN, USA) discussed the tools and skills required by laboratory professionals to integrate AI/ML applications in clinical laboratories. This does not mean that laboratorians will have to become coding experts. According to McClintock, there are simple “low-code and no-code” test systems that can aid non-experts in generating AI/ML models. However, he cautioned that it is still vital to think about datasets critically from the laboratory perspective.

“This is where it is more important not to understand the coding but to understand what the model is looking for,” said McClintock. A laboratorian should be able to answer basic questions when developing and using a model such as: “What am I looking for? How do I structure my data? What are the inputs? What are the outputs?”

McClintock also described some of the obstacles hampering the wider distribution of AI/ML. “We don’t expect one group to figure all this out,” he said. Collaboration is key, and McClintock believes it is important for more people with backgrounds in data science to be brought into the laboratory in order to ensure the right support is in place from both the lab side as well as the IT side.

AI holds the power to transform laboratory medicine, although several questions remain unanswered. “There is a time and place for AI, and we’re going to learn what that is,” said McClintock. Laboratorians must be ready and begin understanding where and how AI/ML can fit in. But McClintock made it clear that “AI and ML are coming to your laboratory.”

Thomas Durant, MD, from Yale School of Medicine (Wallingford, CT, USA) discussed various key issues related to the implementation of AI/ML applications, including ethics, interoperability, and regulatory considerations. Patient safety is a key concern for Durant who emphasized that lab professionals must perform their due diligence before integrating AI tools as there can be biases within a model that could cause potential harm.

“We need to collectively as a field develop some degree of technology literacy around these new applications,” said Durant. From there, an acceptable framework can be developed for validating and verifying the performance of these tools.

Related Links:
University of Oklahoma Health Sciences Center
Mayo Clinic
Yale School of Medicine

Gold Member
Turnkey Packaging Solution
HLX
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit
New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG

Print article

Channels

Molecular Diagnostics

view channel
Image: This joint effort will use samples from KU ADRC research to validate a blood test developed by BYU (Photo courtesy of KU ADRC)

Blood Test for Early Alzheimer’s Detection Could Help Slow Disease Progression

When brain cells, such as those affected by Alzheimer’s disease, die, small fragments of DNA are released into the bloodstream. These fragments, known as cell-free DNA, carry valuable information, including... Read more

Hematology

view channel
Image: Personalized blood count could lead to early intervention for common diseases (Photo courtesy of 123RF)

Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals

A complete blood count (CBC) screening is a standard examination most physicians request for healthy adults. This test is essential for evaluating a patient’s overall health with a single blood sample.... Read more

Immunology

view channel
Image: Concept for the device. Memory B cells able to bind influenza virus remain stuck to channels despite shear forces (Photo courtesy of Steven George/UC Davis)

Microfluidic Chip-Based Device to Measure Viral Immunity

Each winter, a new variant of influenza emerges, posing a challenge for immunity. People who have previously been infected or vaccinated against the flu may have some level of protection, but how well... Read more

Microbiology

view channel
Image: The BIOFIRE® FILMARRAY® Tropical Fever Panel has received U.S. FDA Special 510(k) clearance (Photo courtesy of bioMérieux)

Syndromic PCR Test Rapidly and Accurately Identifies Pathogens in Patients with Tropical Fever Infections

Tropical fevers refer to infections that are common in, or unique to, tropical and subtropical regions. As these diseases spread to previously unaffected areas and can be brought in by travelers, infections... Read more

Pathology

view channel
Image: These images show the high resolution achieved with the new microscopy technique (Photo courtesy of Cao, R. et al. Science Advance, 2024. Caltech)

New Microscopy Technique Enables Rapid Tumor Analysis by Surgeons in OR

The current standard method for quickly sampling and imaging tissue during surgery involves taking a biopsy, freezing the sample, staining it to enhance visibility, and slicing it into thin sections that... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.